Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early selective treatment with Curosurf in preterm infants with RDS
2006-001563-37Phase 4Completed
- Sponsor
- Department of Pediatrics, Holbæk Hospital
- Start
- Oct 2006
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4 trial of Poractant alfa in respiratory distress syndrome (RDS), sponsored by Department of Pediatrics, Holbæk Hospital. Primary endpoint: Mechanical ventilation or death within the first 5 days of life. Started Oct 2006; status: completed.
02
Drugs
Poractant alfa
03
Conditions
respiratory distress syndrome (RDS)
Beyond the preview
Go deeper on 2006-001563-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001563-37.